Announced Tue, 27 Oct, 2026 · 16:23 IST

Board to approve September 2026 quarterly and half-year results

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.3%Reaction day
₹40.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Hospital peers, median of 25sector+0.8%+0.5% vs sector

On the reaction day the stock moved 0.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.3pendingpending+0.8+0.5
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on November 3, 2026 to approve unaudited financial results for the quarter and six months ended September 30, 2026, both for the company alone and together with its subsidiaries. Trading in the company's securities remains closed until 48 hours after the results are announced, up to November 5, 2026.

Likely market impact

No results are provided yet, so there is no confirmed earnings trend or likely price direction. Shareholders should await the November 3 results.